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Abstract  
Background: Cervical Cancer is one of the most important and commonly 
diagnosed types of cancer in females. There are different causes of cervical 
cancer, amongst which recurrent and persistent infection with HPV types 16 and 18 
are the most renowned ones. These genotypes are the main factors in 99 % of 
cases in developed countries and 70 % in developing ones. Due to the importance 
of these viruses in cervical cancer, molecular detection of HPV and its high risk 
genotypes in Gorgan was designed. 
Methods: Pap smears and swabs specimens were taken from 308 women. 
Papanicola staining method and cytology were used. Nucleic acid was extracted 
by proteinase K phenol-chloroform standard method and then assessed by using 
beta-globin primer. Polymerase Chain Reaction (PCR) was then performed for 
papilomaviruses on all patients and positive cases from both types, including HPV 
16 and 18 genotypes, were detected. 
Results: Three hundred and eight women (15-75 years old) with mean age of 
37.54±10.6 were recruited. Seventy six cases (20.1%) of whom were infected 
with HPV and 48.6% with HPV16 or 18 positive. Normal cytology was seen in 
226 cases and 41 patients (18.1%) were HPV positive. Amongst those 152 cases 
with inflammation or abnormal cytology, 35 cases (23%) were HPV positive. No 
significant relation was reported between different variables and HPV infections. 
Conclusions: Due to high rate of HPV infection, as well as its high risk genotypes 
in different studies, more careful screening of women by Pap smear is 
recommended. 
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Introduction 
 Cervical cancer is one of the most prevalent 
and important cancers amongst women. In some 
studies, it is reported as the second most common 
cancer after breast cancer while others consider it as 
the third most common, after breast and lung cancer 
[1-2]. About 465,000 new cases of cervical cancer 
are diagnosed annually, all over the world, and kill 
more than 200,000 people. The incidence rate is 
variable in different population and depends on 
different causes as described below [1]: 
    - 3.8/100,000 in Palestine  
    - 48.2/100,000 in Colombia 
    - 9.8/100,000 (15,700 new cases annually) in 
United States 
 - Finally in Latin America is reported 4 times more 
than USA and other developed countries. 
    
This variation demonstrates the role of different 
etiologies, amongst which recurrent and persistent 
infection with Human Papillomaviruses type 16 and 
18 (HPV-16, 18) are the most important and well-
known causes [2-10].  
In some studies DNA of high-risk Human 
Papillomavirus was detected in more than 95% of 
cervical biopsies. The prevalence of high risk HPVs in 
premalignant stage is more than low risk HPVs i.e. 
(HPV-6, 11) [3]. Other risk factors in cervical cancer 
are as follows: a) initiation of sexual activity at 
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younger age, b) multiple partners, c) long term usage 
of oral contraceptive (OCP) and d) cigarettes [1].  
Given the importance of Human Papillomavirus 
role in cervical cancer and high frequency of HPV 
genital infection, detecting high-risk genotype of 
HPV infection is the best approach to prevent 
malignancy. Unlike other sexually transmitted 
diseases (STD), HPV infection can be asymptomatic 
without causing specific genital lesions (condyloma 
acominota). Due to this feature, the patient might not 
be referred for treatment, giving the virus enough 
time to replicate in cells and to proceed to malignant 
stages in epithelial cells. On the other hand, 
transformation of dysplastic lesions into invasive 
cervical cancer is gradual and without any alarming 
symptoms in most cases [6].  
Several methods have been employed to detect 
HPV infection, amongst which polymerase chain 
reaction (PCR) is considered the most accurate with a 
very high specificity and sensitivity. PCR can also 
detect HPV in cervical biopsy before any cellular 
changes and positive Pap smear.  
This study was designed for molecular detection of 
HPV and its high risk genotypes in the North East of 
Iran. 
Materials and Methods 
Study Population 
We studied 378 women in need of cervical 
Papanicolaou examination in the Academic 
Gynecology Hospital of Gorgan, located in the 
North East of Iran.  
DNA Extraction from Pap Smears 
Two Arye spatulas were used to collect samples: 
One to prepare cervical Pap smear and another for 
cervical sample, which was placed in a tube with 
PBS. The first spatula used for Pap smear was 
washed in the same tube.    
Smears were fixed in alcohol, stained by 
Papanicolaou stains (Orange G, Hematoxylin, and 
EA Polychorome solution consisting of light green 
solfonated acryl-methane dye, eosin, and Bismark 
brown). They were covered by glass slips and finally 
evaluated by a pathologist.  
The second set of samples containing exfoliated 
cervical cells were centrifuged at 3000g per 10 
minutes. The resulting pellet was transferred into a 
1.5 ml Eppendorf microtube containing 200 ml 
digestion buffer (0.2 mol Tris-HCL [PH 7.5], 25 mmol 
EDTA, 0.3 mol NaCl, 2% SDS). Subsequently, 20 mg 
of proteinase K was added, and the cells were 
digested at 60oC for 2 hours. The digested samples 
were extracted twice with phenol-chloroform and 
once with chloroform. 
 The DNA was precipitated by adding 50 ul 
(ml) 3 mol sodium acetate and 1 ml ethanol. After 1 
hour at -70oC, samples were centrifuged for 10 min 
at 14000 rpm. The DNA pellet were dried and 
dissolved in 100 ul TE (10 mmol Tris-HCl [PH 7.5], 
0.1 mmol EDTA). The DNA samples were then tested 
by agarose gel electrophoresis to ensure that no 
degradation has occurred during the extraction.  
In addition, in order to analyze the quality of the 
target DNA, beta-globin (positive samples) gene-
specific primers [PCO3, 5’-ACA CAA CTG TGT TCA 
CTA GC-3’ and PCO4, 5’-CAA CTT CAT CCA CGT 
TCA CC-3’] were used. 
PCR Amplification 
A slight modification was made to the Polymerase 
Chain Reaction (PCR) method as described by Saiki 
et al [11].  The PCR was performed in a total volume 
of 50 μl containing 100 ng of DNA extracted from 
paraffin-embedded tissue, 50 mmol KCl, 10 mmol 
Tris-HCl pH 8.3, 200 μM of each dNTP, 2 to 4 mmol 
MgCl2, 1 U Taq polymerase and 50 picomol of each 
primer. The primers used in this study were 
GP5+/GP6+ pairs with the following sequences [de 
Roba Husman et al: 1995 modified in German 
Cancer Research Center]:  
GP5 + 5´ TTTGTTACTGTGGTA GATACTAC 
GP6 + 5´ GAA AAA TAA ACT GTA AATCATATTC 
The mixture was denatured at 94oC for 5 min, 
followed by 40 cycles of amplification using a PCR 
processor Bio-Med (Perkin Elmer Cetus USA). Each 
cycle consisted of 94oC for 1.5 min, 40oC for 2 min, 
and 72oC for 1.5 min. The final elongation step, 
lasting 4 minutes, was to ensure the complete 
extension of the amplified product. Before and after 
amplification reactions, samples were processed in 
separated rooms to avoid contamination by PCR 
products. Samples containing distilled water were 
used as negative controls.  Ten μl of each PCR 
mixture was finally analyzed by 1.5% agarose gel 
electrophoresis. All positive HPV DNA PCR samples 
were further analyzed for genotyping of HPV. The 
presence of genotypes 16 and 18 were 
investigated. HPV genotyping PCR was carried out 
using specific primers for amplification of the given 
sequence consisting of E6 region of HPV 16 and 18. 
The utilized sequences are: HPV 16 forward, 5’-TCA 
AAA GCC ACT GTG TCC TG-3’ ,reverse 16, 5’-CGT 
GTT CTT GAT GAT CTG CA-3’ , HPV 18, forward ,  
5’-GAC ACA TTG GAA AAA CTA AC-3’ , reverse 
18, 5’-TAG TGC CCA GCT ATG TTG TG-3’. The 
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amplified products correspond to 139bp for HPV 16 
and 119bp for HPV 18.  
Results 
In this study, 378 women between 15 and 75 
years old were recruited with mean age of 37.45 
(±10.6). Seventy six (20.1%) were infected with HPV 
and one patient was diagnosed with Invasive 
carcinoma. Inflammatory or abnormal pap-smears 
were reported in 151 patients and a past history of 
abortion was reported in 110 patients; amongst 
whom 18 cases of HPV infection (5 cases with HPV-
16, 4 cases with HPV-18 and 9 cases with unknown 
specific primers) were detected (Table 1).  
The relation between HPV infection and the 
number of intercourse in a week, as well as the 
results of cytological examination and the number of 
pregnancies are shown in table 2. Three hundred 
and forty nine individuals with a history of at least 
one pregnancy were identified. First pregnancy 
under the age of 19 was reported in 171 cases, 
amongst which 30 cases (17.5%) of HPV positive and 
7 cases of HPV-16 and 3 of HPV-18 were detected. 
Amongst those with the first pregnancy between 
20-29 years old (n=163), 36 cases (22.1%) of HPV 
positive (10 cases of HPV-16 and 10 cases of HPV-
18) were identified. Among 10 pregnancies, 
between 30-39 years old, only one case of HPV 
infection was detected. Given 13 smoker patients 3 
were HPV positive and 2 out of 3 were HPV-18 
positive. The correlation between HPV infection and 
contraceptive are shown in table 3. 
Amid 18 widows, (4.8%) 3 were HPV positive and 
2 out of 3 were HPV-16 positive. For those (N=341 
(90.2%)) who were married once, 70 of them were 
HPV positive (20 with HPV-16 and 15 with HPV-18). 
However, amongst those (5% of patients (N=19)) 
who married twice 3 were diagnosed with infection. 
For those ten individuals whom their husband had a 
history of genital infection, 4 were infected and 2 out 
of 4 were HPV-16 positive. Finally for those 44 
individuals who have used vaginal shower, 4 were 
diagnosed with HPV positive and 2 out of 4 with 
HPV-16 positive. 
Discussion 
Cervical cancer is the second cause of mortality 
amongst women all over the world [12]. Generally in 
60-70 % of cases, genital infection occurs with either 
HPV-16 or HPV-18. In 70 % of cancer cases, these 
two genotypes were responsible and in the 
remaining 30 %, other genotypes were present [13]. 
In the USA, 99% of cervical cancers are due to HPV-
16 and 18 [14]. The American Association of Cancer 
suggests assessment of cervical discharge in parallel 
with pap-smear [15]. 
In the present study, 378 females, between 15 
and 75 years of age, were evaluated; 20.1% of 
whom were infected with HPV (5.8% HPV-16, 4% 
HPV-18 and 10.3% unknown type specific primers).  
In a study in USA the reported incidence rate was 
26.8 % 13, while in Taiwan and Poland it was 
reported as 19.85% and 25.4% respectively 
[16,17]. Although the HPV incidence rate in our 
country seems to be similar to the ones mentioned 
previously but some lower rates, such as 4.8 % in 
Mexico, were reported [18]. 
Our findings have shown a rate of 18.1% of 
infection amongst subjects with normal pap-smear 
and 23% amongst subjects with inflammatory or 
abnormal cytology. In a study in Argentina, the HPV 
infection rate was reported as 64.2% amongst 
subjects with premalignant and malignant lesions [2], 
but other reports did not support this high incidence 
rate [16-17]. Our study has detected an infection 
rate of 23.4% amongst subjects with 25-34 years of 
age and a rate of 11.5% for those older than 54 
years of age. However the incidence rate was 
reported as 12% and 2.4% respectively in Poland 
[10], lower than the present study. In Brazil the rate 
was reported as 32.5% [19] which is more than our 
findings.   
The subjects with highest infection rate were under 
34 years old (23.6%), amongst whom 44.7% were 
diagnosed with HPV-16 and 18. Thus it can be 
assumed that HPV-16 and 18 can be present in 
people with normal and inflammatory cytology [9, 
20]. For those (29.7%) with history of abortion, 
16.3% were diagnosed with HPV (50% with either 
HPV-16 or 18. Other investigators reported HPV 
infection in 53.5% of whom with a history of abortion 
in contrast to 33.3% in others [21-22]. It was 
mentioned that HPV infection rate is 3 times higher in 
abortion [23-24]. 
Our result confirms that infection rate increases as 
the rate of sexual intercourses increases. Other 
investigators suggested that transmission occurs along 
with the sexual contacts and most of the people get 
rid of the virus except the persistent HPV-16 or 18 
infections, which lead to cervical cancer [11]. 
Another study in Poland, illustrated that 16-19 
years old women with more than one sexual partner, 
who have started the sexual activity before age of 
16, have an infection rate of 27% [25].  
Risk factors of HPV are reported as follow: a) 
sexual contact in younger age, b) multi-partnership, 
c) no use of condom, d) and more than two vaginal 
deliveries [16]. But we reported no significant 
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relationship between HPV infection and these factors.  
Although 18.1% of those with normal cytology in 
pap-smear were infected with HPV (amongst whom 
39% are diagnosed with HPV-16 and 18), this rate 
increases up to 23% and 60% respectively for those 
with inflammatory and abnormal cytology. This 
finding is confirmed in other studies as well [2]. 
Amongst those subjects, with 29 years of age and no 
history of pregnancy, 20.7% were infected with HPV 
(83.3% were HPV-16 and 18 positive). Eighteen of 
them were widows and 16.3% of them were infected 
with HPV (66.7% were HPV-16). The subjects 
between 15 to 24 years of age face higher risk of 
infection, due to more sexual contacts. No significant 
differences were detected in regards to HPV 
infection and genotypes 16, 18 in different gravids. 
Table 1. Frequency and distribution of HPV and HPV genotypes in the studied subjects in Gorgan city
 
Age Groups                HPV Positive HPV Negative 
(%) 
Total
(%) 
 HPV-16(%) HPV-18(%) Non-HPV-16, 18 
(%) 
15-24 1 (3) 1 (3) 6 (18.2) 25 (75.8) 33 (8.7)
25-34 8 (6.3) 7 (5.4) 15 (11.7) 98 (76.6) 128 (33.9)
35-44 7 (5.8) 4 (3.4) 12 (6.2 96 (80.6) 119 (31.5)
45-54 5 (6.9) 34.2) 4 (5.6) 60 (83.3) 72 (19)
>54 1 (3.8) 0 2 (7.7) 23 (88.5) 26 (6.9)
Total 22 (5.8) 15 (4) 39 (10.3) 302 (79.9) 378 (100)
 
Table 2. Distribution of HPV genotypes with number of intercourse in a week, results of cytological exam and 
number of pregnancies in the subjects in Gorgan city 
   HPV Positive HPV Negative 
(%) 
Total (%)
  HPV-16
(%) 
HPV-18
(%) 
Non-HPV-16, 
18(%) 
 
 One time 2 (1.4) 2 (1.4) 6 (4.1) 136 (93.1) 146 (100)
*Number of 
intercourse in 
a week 
2-4 time 7 (5.9) 10 (8.4) 22 (18.5) 80 (67.2) 119 (100)
 >4 time 10 (11.9) 3 (3.6) 10 (11.9) 61 (72.6) 84 (100)
Cytological 
exam 
Normal 
 
9 (4.2) 7 (3.2) 25 (11.6) 175 (81) 226 (100)
 Abnormal & 
inflammatory 
15 (9.9) 6 (3.9) 14 (9.2) 117 (77) 152 (100)
Number of 
pregnancy 
non 3 (10.3) 2 (6.9) 1 (3.4) 23 (79.3) 29 (100)
 1-5 15 (5.3) 12 (4.2) 31 (10.9) 227 (79.6) 285 (100)
 >5 4 (6.1) 1 (1.5) 7 (10.6) 54 (81.8) 66 (100)
* Numbers of persons answered the question 
 
Table 3. Frequency of HPV and genotypes and contraceptive methods in study subjects in Gorgan city 
  HPV Positive HPV Negative 
(%) 
Total(%)
 HPV-16(%) HPV-18(%) Non-HPV-16, 
18(%) 
IUD 0 0 1 (9.7) 12 (90.3) 13 (3.4)
Natural 4 (4.8) 1 (1.2) 7 (8.5) 71 (85.5) 83 (22)
Pill 1 (2) 3 (6.1) 5 (10.2) 40 (81.5) 49 (13)
Condom 0 1 (4) 4 (16) 20 (80) 25 (6.6)
Multiple 0 1 (6.2) 3 (18.8) 12 (75) 16 (4.2)
Don’t Use 17 (8.6) 9 (4.8) 19 (9.9) 147 (76.7) 192 (50.8)
Total 22 (5.8) 15 (3.9) 39 (10.4) 302 (79.9) 378 (100)
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In an investigation in Bulgaria, HPV infection was 
reported as 17.7% amongst pregnant women and 
13.1% amongst non-pregnant [26]. In Japan, 
infection rate amongst pregnant women, younger 
than 25 years old, was reported as 22.6% [27]. 
HPV infection, especially HPV-16 and 18, in Gorgan 
city can be considered very important, amongst 
which genital cancer is the third cancer. It seems 
necessary to evaluate HPV-16 and 18 in all women 
referred for pap-smear.  
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